Table 4.
Associations of polymorphisms with rate of decline of lung function in the Vlagtwedde-Vlaardingen cohort, under an additive genetic model adjusted for sex and pack-years of smoking
| Genotype Counts |
|||||||
|---|---|---|---|---|---|---|---|
| SNP | Gene | Genotype | Nondecliners | Fast Decliners | Odds Ratio | 95% Confidence Interval | P Value |
| rs9573956 | IRG1 | AA | 0 | 1 | 1.279 | 0.772–2.120 | 0.340 |
| AG | 35 | 32 | |||||
| GG | 260 | 196 | |||||
| rs3092794 | NCOA3 | AA | 59 | 45 | 0.915 | 0.703–1.190 | 0.507 |
| AG | 152 | 112 | |||||
| GG | 67 | 64 | |||||
| rs6125042 | NCOA3 | CC | 4 | 2 | 0.978 | 0.603–1.584 | 0.927 |
| TC | 40 | 25 | |||||
| TT | 176 | 120 | |||||
| rs9565305 | IRG1 | GG | 0 | 1 | 1.188 | 0.723–1.952 | 0.496 |
| TG | 38 | 32 | |||||
| TT | 251 | 191 | |||||
| rs11085735 | KEAP1 | GG | 266 | 205 | 1.133 | 0.642–1.999 | 0.667 |
| TG | 27 | 24 | |||||
| TT | 1 | 0 | |||||
| rs17708487 | BACH2 | AA | 168 | 116 | 1.198 | 0.903–1.591 | 0.211 |
| AG | 102 | 94 | |||||
| GG | 19 | 16 | |||||
| rs8176199 | BRCA1 | AA | 172 | 126 | 1.137 | 0.856–1.511 | 0.375 |
| AC | 98 | 82 | |||||
| CC | 17 | 18 | |||||
| rs634534 | FOSL1 | AA | 45 | 49 | 1.374 | 1.060–1.781 | 0.016 |
| AG | 147 | 119 | |||||
| GG | 102 | 57 | |||||
| rs16882297 | BACH2 | CC | 261 | 211 | 0.629 | 0.331–1.198 | 0.158 |
| GC | 28 | 15 | |||||
| GG | 1 | 0 | |||||
| rs5758223 | EP300 | AA | 157 | 120 | 0.850 | 0.638–1.132 | 0.266 |
| AG | 99 | 88 | |||||
| GG | 29 | 9 | |||||
| rs4722029 | GNA12 | CC | 12 | 24 | 1.206 | 0.908–1.603 | 0.196 |
| TC | 106 | 67 | |||||
| TT | 172 | 131 | |||||
| rs20552 | EP300 | AA | 126 | 90 | 0.965 | 0.744–1.252 | 0.789 |
| TA | 126 | 114 | |||||
| TT | 43 | 23 | |||||
| rs1915919 | PCAF | CC | 109 | 83 | 0.952 | 0.736–1.231 | 0.706 |
| TC | 127 | 108 | |||||
| TT | 47 | 31 | |||||
| rs176713 | BACH2 | AA | 224 | 156 | 1.367 | 0.950–1.967 | 0.092 |
| AG | 64 | 65 | |||||
| GG | 4 | 4 | |||||
| rs6808352 | PCAF | GG | 31 | 18 | 0.920 | 0.700–1.209 | 0.549 |
| TG | 115 | 96 | |||||
| TT | 138 | 109 | |||||
| rs427967 | NCOA3 | CC | 187 | 160 | 0.830 | 0.586–1.173 | 0.291 |
| TC | 84 | 57 | |||||
| TT | 8 | 5 | |||||
| rs9344981 | BACH2 | CC | 91 | 70 | 0.970 | 0.758–1.241 | 0.806 |
| TC | 132 | 111 | |||||
| TT | 68 | 45 | |||||
| rs4951627 | ATF3 | CC | 14 | 9 | 1.093 | 0.800–1.492 | 0.577 |
| CG | 80 | 72 | |||||
| GG | 194 | 141 | |||||
| rs13001694† | NFE2L2 | CC | 95 | 82 | 0.878 | 0.678–1.137 | 0.323 |
| TC | 145 | 116 | |||||
| TT | 52 | 32 | |||||
| rs9565304 | IRG1 | AA | 241 | 178 | 1.253 | 0.819–1.918 | 0.298 |
| AG | 48 | 47 | |||||
| GG | 2 | 1 | |||||
| rs3846991 | GNA12 | CC | 32 | 42 | 1.221 | 0.943–1.582 | 0.130 |
| CG | 142 | 98 | |||||
| GG | 114 | 84 | |||||
| rs831172 | IRG1 | AA | 106 | 78 | 1.135 | 0.873–1.476 | 0.346 |
| AG | 146 | 114 | |||||
| GG | 37 | 37 | |||||
| rs2143491 | NCOA3 | CC | 100 | 88 | 0.978 | 0.747–1.280 | 0.871 |
| TC | 156 | 106 | |||||
| TT | 35 | 31 | |||||
The odds ratios are for a rapid rate of decline, and the reference is the wild-type homozygote genotype.
In almost complete linkage disequilibrium (r2 = 0.964) with SNP rs10183914 according to HapMap.